ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Other Financing Activities
Financing cash flows not reported separately.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities turns positive
Q1 FY2026 other financing activities was $45.25M, compared with -$9.45K a year earlier. Trailing-twelve-month other financing activities was $44.86M. Over 3 fiscal years it compounded at -35.0% a year.
Context
- Other financing activities amounted to 1.7% of revenue in FY2025, down 67076801.4 pp from a year earlier.
- Other financing activities increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly other financing activities holds near $45.25M or moves back toward the trailing-twelve-month quarterly average of $11.21M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (402K) USD
- Year-over-year change
- -100.0%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (402K) | -100.0% |
| FY2024 | 2024-12-31 | 2.78T | +493309046.2% |
| FY2023 | 2023-12-31 | (563.47K) | +61.6% |
| FY2022 | 2022-12-31 | (1.47M) | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Financing Activities vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +686.2% is the highest of 11, against a peer median of +27.1%.
- Other financing activities amounts to 166.6% of revenue for ASPI, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$427.96M BRL | -1628.4% | — | 0.6% | |
| LTM Mar 2026 | $282.35M USD | -6.1% | -8.4% | 22.9% | |
| LTM Mar 2026 | $44.86M USD | +686.2% | -35.0% | 166.6% | |
| LTM Mar 2026 | $37.97M USD | -9.0% | +37.8% | 2.8% | |
| LTM Mar 2026 | $30.5M USD | +246.6% | +103.8% | 2.4% | |
| LTM Mar 2026 | $16.15M USD | +589.9% | -41.6% | 0.8% | |
| LTM Mar 2026 | $2.98M USD | +11.1% | -53.5% | 2.2% | |
| LTM Mar 2026 | $2.04M USD | +43.1% | -3.6% | 0.1% | |
| LTM Mar 2026 | $1.47M USD | +82.8% | — | 3.8% | |
| LTM Mar 2026 | $1M USD | -94.1% | +144.5% | 0.0% | |
| LTM Apr 2026 | $0 USD | +100.0% | — | 0.0% | |
| Peer median (excluding ASPI) | — | +27.1% | -3.6% | 1.5% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.61M) | (4.95M) | (16.29M) | (32.42M) | (159.84M) |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471.42B | 1.91M |
| Deferred Income Tax | 0 | (72.57K) | 16.66K | (143.28K) | (45K) |
| Stock-Based Compensation | 0 | 2M | 8.74M | 8.56M | 16.02M |
| Change in Working Capital | (238.21K) | 33.89K | 1.16M | (2.62M) | (3.63M) |
| Accounts Receivables | 0 | 0 | 237.95K | (505.95K) | (454K) |
| Inventory | 0 | 0 | 0 | (67.64K) | (315K) |
| Accounts Payables | 59.68K | 570.6K | (224.6K) | (877.47K) | 782K |
| Other Working Capital | (297.89K) | (536.71K) | 1.15M | (1.17M) | (3.64M) |
| Other Non-Cash Items | 2.23M | (27.96K) | 924.12K | (471.41B) | 107.8M |
| Operating Cash Flow | (577.69K) | (2.94M) | (5.41M) | (16.7M) | (37.78M) |
| Capital Expenditures | (2.99M) | (4.47M) | (2.33M) | (11.37M) | (9.65M) |
| Acquisitions (Net) | 0 | 0 | (121.85K) | 0 | 25.37M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (75.74M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (29.97M) |
| Investing Cash Flow | (2.99M) | (4.47M) | (2.45M) | (11.37M) | (90M) |
| Debt Repayment | 46.9K | (13.05K) | (180.53K) | 25.72M | 44.11M |
| Common Stock Issued | 6.45M | 8.12M | 14.13M | 53.09M | 307.09M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (2.78T) | 0 |
| Other Financing Activities | 0 | (1.47M) | (563.47K) | 2.78T | (402K) |
| Financing Cash Flow | 6.5M | 6.64M | 13.39M | 82.53M | 350.8M |
| Effect of Forex Changes | 18.72K | 207.42K | (867) | (484.01K) | 646.95K |
| Net Change in Cash | 2.93M | (564.58K) | 5.52M | 53.98M | 223.67M |
| Free Cash Flow | (3.57M) | (7.41M) | (7.74M) | (28.07M) | (47.43M) |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.